title: Nifedipine labeling illustrates the pediatric dilemma for off-patent drugs.
authors.affiliation: Louisiana State University Health Services Center, Shreveport 71130, USA.
authors.forename: Kim G
authors.initials: KG
authors.lastname: Adcock
authors.forename: John T
authors.initials: JT
authors.lastname: Wilson
mesh_terms: D002648:Child; D004348:Drug Labeling / Q000592:standards*; D006801:Humans; D009543:Nifedipine / Q000627:therapeutic use*; D009965:Orphan Drug Production / Q000331:legislation & jurisprudence; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D010372:Pediatrics / Q000331:legislation & jurisprudence* / Q000592:standards; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D009543:Nifedipine